Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (191-200 of 750) with videos related to

Pageof 75
Sort By:
Clinical and Molecular Hepatology|February 17, 2025
The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on "Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023"Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Seminars in Arthritis and Rheumatism|January 30, 2023
Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis reviewKelly Torosian, Esha Lal, Arthur Kavanaugh, et al.
Cardiology in the Young|August 2, 2023
Echocardiographic measured shunt velocity does not predict pulmonary blood flow in patients with Blalock-Thomas-Taussig shuntSarah Tucker, Matthew Cornicelli, Rohit Loomba, et al.
Alimentary Pharmacology & Therapeutics|January 11, 2025
Current Burden of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Among US Adults, 2017-2023Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
The American Journal of Medicine|March 3, 2018
Geographic Variability in Liver Disease-Related Mortality Rates in the United StatesArchita P Desai, Prashanthinie Mohan, Anne M Roubal, et al.
Hepatology (Baltimore, Md.)|May 18, 2023
Reply: ELF in the risk stratification of NAFLD-Are the ELF thresholds suggested by the AASLD guidelines appropriate?Mary E Rinella, Norah Terrault, Brent Neuschwander-Tetri, et al.
Clinical and Molecular Hepatology|February 13, 2025
Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on "Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023"Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Clinical and Molecular Hepatology|November 29, 2024
Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Journal of Hepatology|August 21, 2023
Progression of non-alcoholic fatty liver disease and long-term outcomes: A nationwide paired liver biopsy cohort studyTracey G Simon, Bjorn Roelstraete, Hannes Hagström, et al.
Alimentary Pharmacology & Therapeutics|May 11, 2021
The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastographyVeeral Ajmera, Amy Liu, Ricki Bettencourt, et al.
Pageof 75

Showing results (191-200 of 750) with videos related to

Sort By:
Pageof 75
Clinical and Molecular Hepatology|February 17, 2025
The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on "Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023"Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Seminars in Arthritis and Rheumatism|January 30, 2023
Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis reviewKelly Torosian, Esha Lal, Arthur Kavanaugh, et al.
Cardiology in the Young|August 2, 2023
Echocardiographic measured shunt velocity does not predict pulmonary blood flow in patients with Blalock-Thomas-Taussig shuntSarah Tucker, Matthew Cornicelli, Rohit Loomba, et al.
Alimentary Pharmacology & Therapeutics|January 11, 2025
Current Burden of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Among US Adults, 2017-2023Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
The American Journal of Medicine|March 3, 2018
Geographic Variability in Liver Disease-Related Mortality Rates in the United StatesArchita P Desai, Prashanthinie Mohan, Anne M Roubal, et al.
Hepatology (Baltimore, Md.)|May 18, 2023
Reply: ELF in the risk stratification of NAFLD-Are the ELF thresholds suggested by the AASLD guidelines appropriate?Mary E Rinella, Norah Terrault, Brent Neuschwander-Tetri, et al.
Clinical and Molecular Hepatology|February 13, 2025
Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on "Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023"Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Clinical and Molecular Hepatology|November 29, 2024
Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Journal of Hepatology|August 21, 2023
Progression of non-alcoholic fatty liver disease and long-term outcomes: A nationwide paired liver biopsy cohort studyTracey G Simon, Bjorn Roelstraete, Hannes Hagström, et al.
Alimentary Pharmacology & Therapeutics|May 11, 2021
The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastographyVeeral Ajmera, Amy Liu, Ricki Bettencourt, et al.
Pageof 75